| Authors: |
Bourdely P; Centre for Inflammation Biology and Cancer Immunology, The Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK; Cancer Research UK King's Health Partner Cancer Centre, King's College London, London, UK., Anselmi G; Centre for Inflammation Biology and Cancer Immunology, The Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK; Cancer Research UK King's Health Partner Cancer Centre, King's College London, London, UK., Vaivode K; Centre for Inflammation Biology and Cancer Immunology, The Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK; Cancer Research UK King's Health Partner Cancer Centre, King's College London, London, UK., Ramos RN; PSL Research University, Institut Curie Research Center, Translational Immunotherapy Team, INSERM U932, Paris, France., Missolo-Koussou Y; PSL Research University, Institut Curie Research Center, Translational Immunotherapy Team, INSERM U932, Paris, France., Hidalgo S; PSL Research University, Institut Curie Research Center, Translational Immunotherapy Team, INSERM U932, Paris, France; Laboratory of Immuno-oncology, Fundación Ciencia & Vida, Santiago, Chile., Tosselo J; PSL Research University, Institut Curie Research Center, Translational Immunotherapy Team, INSERM U932, Paris, France., Nuñez N; PSL Research University, Institut Curie Research Center, Translational Immunotherapy Team, INSERM U932, Paris, France., Richer W; PSL Research University, Institut Curie Research Center, Translational Immunotherapy Team, INSERM U932, Paris, France., Vincent-Salomon A; PSL Research University, Institut Curie, Department of Biopathology, Paris, France., Saxena A; National Institute of Health Research Biomedical Research Centre at Guy's and St Thomas' Hospital and King's College London, London, UK., Wood K; National Institute of Health Research Biomedical Research Centre at Guy's and St Thomas' Hospital and King's College London, London, UK., Lladser A; Laboratory of Immuno-oncology, Fundación Ciencia & Vida, Santiago, Chile; Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago, Chile., Piaggio E; PSL Research University, Institut Curie Research Center, Translational Immunotherapy Team, INSERM U932, Paris, France., Helft J; PSL Research University, Institut Curie Research Center, Translational Immunotherapy Team, INSERM U932, Paris, France., Guermonprez P; Centre for Inflammation Biology and Cancer Immunology, The Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK; Cancer Research UK King's Health Partner Cancer Centre, King's College London, London, UK; Université de Paris, Centre for Inflammation Research, CNRS ERL8252, INSERM1149 Paris, France. Electronic address: pierre.guermonprez@kcl.ac.uk. |
